We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




First-of-Its-Kind AI-Enabled Service Digitizes Glass Slides to Help Labs Create Digital Pathology Repositories

By LabMedica International staff writers
Posted on 25 Mar 2022
Print article
Image: Digitized pathology slides and associated metadata (Photo courtesy of Pramana, Inc.)
Image: Digitized pathology slides and associated metadata (Photo courtesy of Pramana, Inc.)

Despite the potential value and impact of digitizing pathology archives, few pathology labs have achieved large scale digital libraries. Due to the vastly different slide preparation methods over the years as well as the deterioration of slides in storage, the highly labor-intensive process often results in poor quality and inconsistent images. Now, a vertically integrated solution offers a completely automated means for digitization at scale, enabling significant operational efficiencies by limiting human intervention.

Pramana, Inc. (Cambridge, MA, USA) has launched its Digital Pathology as a Service (DPaaS) solution for creating digital pathology repositories. The DPaaS platform offers a first-of-its-kind service to efficiently digitize pathology slides to meet the needs of pathologists, researchers, and clinicians. Pramana uses its intelligent whole slide image acquisition system, fed by a robot and analyzed by proprietary algorithms, to achieve 100% real-time, fully automated quality assessment. A single scanning cluster is capable of scanning over 1,000 slides per day, and Pramana can scale up or down efficiently to achieve customer-desired throughput. Pramana has announced its first commercial agreement with Mayo Clinic, a multi-year collaboration that includes an industry-leading initiative to digitize five million slides – one of the largest digitization efforts in the world to date, at an unprecedented rate.

“It is often misconstrued that the challenges with going digital for tissue and body fluid slides end with the purchase of a scanner,” said Prasanth Perugupalli, Chief Product Officer at Pramana. “We realized that the greater pain and costs lie in the human capital needed to operate the scanners, which includes making the correct parametric selections and qualifying each whole slide image for any errors after the scanning is completed. Pramana’s DPaaS solution overcomes these challenges with minimal burden on the labs and delivers quality-assured whole slide images with standardized and open data formats.”

Related Links:
Pramana, Inc. 

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.